Preferred Stock Dividends Paid (Quarterly)

Preferred Stock Dividends Paid: The cash outflow for dividends paid on a company's preferred stock.

Sarepta Therapeutics, Inc. (SRPT) Preferred Stock Dividends Paid data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$611.09M
Net Income	$196.89M
Cost of Goods Sold	$152.56M
Gross Profit	$458.53M
Operating Expenses	$495.51M
Operating Income	$115.58M
Non-Operating Income/Expense	$38.06M
Pre-Tax Income	$153.64M
Normalized Pre-Tax Income	$153.64M
Income after Taxes	$196.89M
Income from Continuous Operations	$196.89M
Consolidated Net Income/Loss	$196.89M
Normalized Income after Taxes	$196.89M
EBIT	$115.58M
EBITDA	$124.55M
Weighted-Average Shares Outstanding (Basic)	98.00M
Weighted-Average Shares Outstanding (Diluted)	106.62M
Earnings per Share (EPS) (Basic)	$2.01
Earnings per Share (EPS) (Diluted)	$1.89
Balance Sheet Financials
Current Assets	$2.66B
Property, Plant, and Equipment	$371.86M
Long-Term Assets	$1.02B
Total Assets	$3.68B
Current Liabilities	$919.95M
Long-Term Debt	$1.14B
Long-Term Liabilities	$1.40B
Total Liabilities	$2.32B
Common Equity	$1.36B
Tangible Shareholders Equity	$1.36B
Shareholders Equity	$1.36B
Common Shares Outstanding	97.71M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-322.10M
Cash Flow from Investing Activities	$-258.97M
Cash Flow from Financial Activities	$-11.35M
Beginning Cash	$1.12B
End Cash	$526.18M
Increase/Decrease in Cash	$-592.41M
Stock-Based Compensation	$78.45M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.89
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.46
Debt to Equity Ratio	0.84
Gross Margin	75.04%
Operating Margin	18.91%
EBIT Margin	18.91%
EBITDA Margin	--
Pre-Tax Profit Margin	25.14%
Profit Margin	32.22%
Free Cash Flow	$-397.55M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.17
Inventory Turnover	0.15
Receiveable Turnover	1.16
Days Sales in Receivables	77.66
Return on Equity	14.51%
Return on Tangible Equity	14.51%
Return on Assets	5.35%
Return on Investments	7.89%
Book Value Per Share	$13.89
Free Cash Flow per Share	$-3.73
Operating Cash Flow per Share	$-3.02

Data from Zacks Investment Research, Inc.